Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy

Journal of the Neurological Sciences

Volumn 291, Issue 1-2, 2010, Pages 103-106

  Faivre, Anthony ^a,b   Franques, Jérome ^b   De Paula, Andre Maues ^c   Gutierrez, Mariana ^b   Bret, Sandie ^b   Aubert, Sandrine ^c   Attarian, Shahram ^b   Pouget, Jean ^b  

^a Military Teaching Hospital Sainte Anne   (France)

^b Centre de Référence national pour les Maladies Neuromusculaires   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Acute; Crohn's disease; Encephalopathy; Infliximab; Neuropathy; Tumor necrosis factor alpha

Indexed keywords

AZATHIOPRINE; ETIRACETAM; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IMMUNOGLOBULIN; INFLIXIMAB; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; APRAXIA; ARTICLE; AUTOIMMUNE DISEASE; BRAIN DISEASE; CASE REPORT; CLINICAL ASSESSMENT; CROHN DISEASE; DISEASE SEVERITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; GRAND MAL SEIZURE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LUMBAR PUNCTURE; MOTOR DYSFUNCTION; MOTOR NEUROPATHY; NERVE CONDUCTION; NEUROFIBROMATOSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCORING SYSTEM; SENSORY NEUROPATHY; SKIN EXAMINATION; SKIN MANIFESTATION; TENDON REFLEX; TREATMENT DURATION;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BRAIN; BRAIN DISEASES; CROHN DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MOTOR NEURON DISEASE; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; SENSORY RECEPTOR CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77349108778     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.01.004     Document Type: Article

References (17)

1. Ramos-Casals M., Brito-Zerón P., Soto M.J., Cuadrado M.J., and Khamashta M.A. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 22 (2008) 847-861
2. Fee D.B., and Kasarskis E.J. Myasthenia gravis associated with etanercept therapy. Muscle Nerve 39 (2009) 866-870
3. Stubgen J.P. Tumor necrosis factor-antagonists and neuropathy. Muscle Nerve 37 (2008) 281-292
4. Mohan N., Edwards E.T., Cupps T.R., Oliverio P.J., Sandberg G., Crayton H., et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44 (2001) 2862-2869
5. Shin I.S., Baer A.N., Kwon H.J., Papadopoulos E.J., and Siegel J.N. Guillain-Barre and Miller Fisher syndrome occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54 (2006) 1429-1434
6. Richez C., Blanco P., Lagueny A., Schaeverbeke T., and Dehais J. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology 64 (2005) 1468-1470
7. Hooper D.R., Tarnopolsky M.A., and Baker S.K. Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis. Muscle Nerve 38 (2008) 1318-1325
8. Lozeron P., Denier C., Lacroix C., and Adams D. Long-term course of demyelinating neuropathies occuring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 66 (2009) 490-497
9. Hughes R.A., and Cornblath D.R. Guillain-Barré syndrome. Lancet 366 (2005) 1653-1666
10. Drouet A., Wolkenstein P., Lefaucheur J.P., Pinson S., Combemale P., Gherardi R.K., et al. Neurofibromatosis 1-associated neuropathies: a reappraisal. Brain 127 (2004) 1993-2009
11. Yuki N., Kuwabara S., Koga M., and Hirata K. Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile. J Neurol Sci 168 (1999) 121-126
12. Anderson N.E., and Barber P.A. Limbic encephalitis, a review. J Clin Neurosci 15 (2008) 961-971
13. Miller F.W., Hess E.V., Clauw D.J., Hertzman P.A., Pincus T., Silver R.M., et al. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43 (2000) 243-249
14. Richette P., Dieude P., Damiano J., Liote F., Orcel P., and Bardin T. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoïd arthritis. J Rheumatol 31 (2004) 2079-2081
15. Tracey D., Klareskog L., Sasso E.H., Salfeld J.G., and Tak P.P. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117 (2008) 244-279
16. Gondim F.A.A., Brannagan T.H., Sander H.W., Chin R.L., and Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 128 (2005) 867-879
17. Ichiyama T., Shoji H., Takahashi Y., Matsushige T., Kajimoto M., Inuzuka T., et al. Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis. Cytokine 44 (2008) 149-153